Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | ACSL5 |
| Gene Name: | ACSL5 |
| Protein Full Name: | Long-chain-fatty-acid--CoA ligase 5 |
| Alias: | ACS2; ACS5; Acyl-CoA synthetase long-chain family member 5; EC 6.2.1.3; FACL5; FACL5 for fatty acid coenzyme A ligase 5; Fatty-acid-Coenzyme A ligase, long-chain 5; LACS 5; Long-chain acyl-CoA synthetase 5; Long-chain fatty acid coenzyme A ligase 5; Long-chain-fatty-acid-CoA ligase 5 |
| Mass (Da): | 75991 |
| Number AA: | 683 |
| UniProt ID: | Q9ULC5 |
| Locus ID: | 51703 |
| COSMIC ID: | ACSL5 |
| Gene location on chromosome: | 10q25.1-q25.2 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 19688 |
| Percent of cancer specimens with mutations: | 0.51 |
| Normal role description: | Lipid Metabolism - fatty acid; Ligase; shown to play a role in glioma cell survival under acidosis conditions. |